‘Live’ Virus Research Impacts Pandemic Insights
To solve the challenges presented by COVID-19, it's important to look to the past. History shows that collaboration is the way forward when uncovering secrets of an emerging virus. It is vital for many reasons, a key one being safety. Only a few labs can safely handle a "live," meaning infectious, sample.
No one knows that better than Hideki Ebihara, Ph.D., a Mayo Clinic virologist who leads Mayo's Emerging Virus Program. As a researcher with worldwide connections and deep experience studying emerging diseases, Dr. Ebihara and his lab are vital to Mayo's COVID-19 research efforts.
From the lab to clinical trials, and from diagnostics to decontamination, Dr. Ebihara's lab is a lynchpin for SARS-CoV-2 research that improves care and fosters a safe working environment at Mayo Clinic.
Having this facility to support Mayo's research, medical practice and education activities means good ideas can move into patient care for use when they’re needed.
Read more about this crucial laboratory in the fight against COVID-19 and other pandemics in Discovery's Edge, Mayo Clinic's research magazine offering insight into the process and progress of medical science at the world's largest group medical practice.